Nicholas Investment Partners’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-105,771
| Closed | -$6.47M | – | 188 |
|
|
2020
Q3 | $6.47M | Buy |
+105,771
| New | +$6.47M | 0.7% | 51 |
|
|
2019
Q4 | – | Sell |
-59,761
| Closed | -$8.38M | – | 231 |
|
|
2019
Q3 | $8.38M | Sell |
59,761
-17,855
| -23% | -$2.5M | 0.71% | 33 |
|
|
2019
Q2 | $14.2M | Sell |
77,616
-2,562
| -3% | -$469K | 1.3% | 9 |
|
|
2019
Q1 | $12.8M | Buy |
80,178
+26,815
| +50% | +$4.26M | 1.14% | 10 |
|
|
2018
Q4 | $5.11M | Sell |
53,363
-25,813
| -33% | -$2.47M | 0.55% | 55 |
|
|
2018
Q3 | $11.2M | Sell |
79,176
-1,818
| -2% | -$257K | 0.9% | 18 |
|
|
2018
Q2 | $12.7M | Buy |
80,994
+19,048
| +31% | +$2.98M | 0.89% | 9 |
|
|
2018
Q1 | $9.98M | Buy |
61,946
+22,894
| +59% | +$3.69M | 0.71% | 15 |
|
|
2017
Q4 | $6.43M | Sell |
39,052
-3,121
| -7% | -$514K | 0.43% | 53 |
|
|
2017
Q3 | $2.63M | Sell |
42,173
-33,632
| -44% | -$2.09M | 0.18% | 188 |
|
|
2017
Q2 | $6.04M | Sell |
75,805
-254
| -0.3% | -$20.2K | 0.43% | 54 |
|
|
2017
Q1 | $5.41M | Sell |
76,059
-11,100
| -13% | -$789K | 0.38% | 78 |
|
|
2016
Q4 | $4.45M | Buy |
87,159
+15,676
| +22% | +$800K | 0.34% | 112 |
|
|
2016
Q3 | $3.29M | Buy |
+71,483
| New | +$3.29M | 0.22% | 184 |
|
|
2016
Q2 | – | Sell |
-58,580
| Closed | -$1.88M | – | 327 |
|
|
2016
Q1 | $1.88M | Sell |
58,580
-3,209
| -5% | -$103K | 0.14% | 241 |
|
|
2015
Q4 | $3.6M | Sell |
61,789
-7,338
| -11% | -$428K | 0.25% | 172 |
|
|
2015
Q3 | $2.93M | Buy |
69,127
+12,375
| +22% | +$524K | 0.21% | 202 |
|
|
2015
Q2 | $4.14M | Buy |
56,752
+506
| +0.9% | +$36.9K | 0.27% | 136 |
|
|
2015
Q1 | $2.83M | Sell |
56,246
-8,940
| -14% | -$449K | 0.18% | 220 |
|
|
2014
Q4 | $2.39M | Buy |
65,186
+1,001
| +2% | +$36.6K | 0.15% | 229 |
|
|
2014
Q3 | $2.02M | Buy |
+64,185
| New | +$2.02M | 0.13% | 239 |
|